Correction: Phase I/Ib Clinical Trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors.

Details

Language :

English

ISSN :

1557-3265

Volume :

30

Issue :

17

Database :

MEDLINE

Journal :

Clinical cancer research : an official journal of the American Association for Cancer Research

Accession number :

39224022

Full Text :

https://doi.org/10.1158/1078-0432.CCR-24-2131